Description: VA reserve and capital reforms are effective 1/1/20 and the first year of reporting under the new framework requires several key milestones for annuity valuation actuaries to achieve. Discuss key implementation issues, including the new standard projection, optionality around hedge treatment and taxation, discuss disclosure requirements as well as the PBR report requirements. Overall focus on decisions to be taken by a valuation actuary with respect to reporting under the new framework.

Description: After 23 years, the new guidelines for insurance contracts have been released, which describe life insurance economic behavior and show its operating results in an unprecedented and complex accounting language. The management of the insurance industry, as well as accounting and actuarial professionals, will face new challenges. This speech started from the basic logic of accounting and the framework of the standards, combined with the insurance industry's operating rules and accounting characteristics, to illustrate the orientation of the new insurance contract standards. From the internal and external perspectives of life insurance operation, this paper used common management language to discuss the understanding of the new insurance contract standards, the focus issues of the industry and the key issue of the effective implementation of the new standards -- the deep integration of accounting and actuarial.

Description: This is an EA1 study note will present some common examples of converting benefits for normal, early and late retirement. It will also analyze how changes in a plan's actuarial equivalence assumption can affect the magnitude of the converted benefits.

Description: This study note will cover the fundamental requirements for a plan to attain qualification and the advantages that qualified status bestows upon those involved in the plan.

Description: Cast study for Spring 2009 Retirement Benefits, U.S.

Description: Due to the development of mobile internet, Chinese insurers now have a variety of valuable ways to collect and use customers' health data.The speaker will share his experience in heath data application in the following fields:Using data to customize health information and suggestion for customers;Using data to stimulate customers' needs for insurance products; and Using data to provide tailor-made products and services

Description: Hear an overview of InsurTech trends and challenges globally. Then, presenters will dive deeper to talk about InsurTech's application in insurance product distribution via smartphones and insurance company's risk selection, risk evaluation, risk control and the related challenges brought to actuaries. Specific applications and cases will be presented.

Description: Learn various ways that actuaries are an making an impact on social issues such as healthcare, public health and climate change. Do you ever wonder if the actuarial profession is doing more than making bottom line revenue for its employers? Hear directly from multiple actuaries who are following their vocation by utilizing their actuarial skills to address real societal issues.

Description: This second session in the series examines responses to the changing workplace landscape from outside the insurance industry. Using a question-and-answer approach with our panelists, this session focuses on practical approaches to identifying new opportunities, and ways in which traditional products and sales channels are changing to meet emerging needs. Compared with other vertical financial services, the life insurance industry has a very low level of 'touch' with its customers. Communication with customers is often limited to the annual mailing of premium invoices. Wellness platforms offer life insurers a means to increase customer engagement, building stronger brand affinity and improving persistency. Life insurers can also leverage customer data collected through the wellness platform to streamline the underwriting process for cross-sales, increasing volume and efficiency.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.